跳至主要内容
临床试验/NCT06433622
NCT06433622Enrolling By Invitation不适用

Platelet Transfusion and Repeat Thromboelastography With Platelet Mapping (TEG-PM) in Patients With Severe Traumatic Brain Injuries (TBI) on Antiplatelet Therapy

Lancaster General Hospital1 个研究点 分布在 1 个国家目标入组 225 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
225
试验地点
1
主要终点
Repeat TEG

研究概览

简要总结

The aim of this study is to see if administering platelets (cells in our blood that stop or prevent bleeding) results in improved platelet function and slows/stops the progression of a head bleed for patients who have a traumatic head bleed and are on antiplatelet therapy (medications that stop blood cells from forming a blood clot) prior to admission.

详细描述

This study aims to determine if platelet function has improved following platelet transfusion by prospectively performing repeat thromboelastographic with platelet mapping (TEG-PM) assays on all patients consented and enrolled in the study. This study will also examine the rate of progression or stability of ICH on repeat head CT following platelet administration and will aid in the determination of a potential association between repeat CT head findings and the repeat TEG-PM results.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Repeat TEG

时间窗: 1 hour after platelets given

Rate of reversed pathway inhibition on repeat thromboelastography with platelet mapping (TEG-PM) when platelets are administered to TICH patients who are on antiplatelet therapy prior to admission.

Repeat Head CT

时间窗: From the time of interventional platelet administration until the time of patient discharge from their index admission, assessed up to 100 weeks.

Number of patients with improved platelet function on repeat TEG-PM and stability of TICH on subsequent CT scan.

次要结局

  • Need for Neurosurgical Intervention(During index admission for traumatic intracranial hemorrhage (TICH), assessed through study completion, an average of 2 years.)
  • Discharge Status(From the time of interventional platelet administration until the time of patient discharge from their index admission assessed through study completion, an average of 2 years.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lindsey Perea

Trauma and Acute Care Surgeon

Lancaster General Hospital

研究点 (1)

Loading locations...

相似试验